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Materials and Methods
Generation of knock in mice expressing D272A-MARF1 mutant protein
Cas9 mRNA and sgRNA were produced as described previously (1) . Briefly, T7 promoter was inserted into the PX330 vector, and the fragment harboring T7-Cas9 sequences was then amplified by PCR using the primers shown in Supplementary Table 2 to serve as the template for in vitro transcription (IVT). Specific sgRNAs targeting the codon D272 of Marf1 gene were designed using the online tool for design of sgRNAs (http://crispr.mit.edu/), and cloned into the PX330 vector to serve as the template for IVT . IVT of Cas9 mRNA and sgRNA was carried out using the mMESSAGE mMACHINE T7 ultra transcription kit (Ambion, USA) and MEGA short script T7 kit (Ambion, USA), respectively. The resultant RNA was then purified by phenol:chloroform extraction and ethanol precipitation, and dissolved in DNase/RNase-free water (Life Technologies, USA) for microinjection. The specificity of the sgRNA was first verified in vitro by microinjection of the sgRNA and Cas9 mRNA into zygotes and test the incision activity in the blastocysts derived from them. The sgRNA with the sequence of AGTGATCTTAGGCACCGGCA was proved to have the optimal specificity. Donor DNA for HDR (homology directed repair) was synthesized by Sangon Biotech (Shanghai, China), in which the codon D272 of Marf1 was mutated into A272.
Its sequence reads: 5'-ATGCTTGTATTTTTCCTTTCAGCTGCTGTCAATTTTGCCTTGGAACT CAGTGATCTTAGGCATCGGCACGGTTTCCACATCATTTTGGTACATAAAAACCAGGCCT CTGAAGCCTTGTTACATCATGCTA-3'. The mixture of Cas9 mRNA (100 ng/µl), sgRNA (50 ng/µl) and donor DNA (10-20 ng/µL) were then microinjected into the cytoplasm of the zygotes that are on a B6DBA2 genetic background in CZB (Chatot-Ziomek-Bavister) medium. After the injected zygotes reached the 2-cell stage in culture, they were transferred into the oviduct of the surrogate pseudopregnant ICR female mice (18-20 embryos/per recipient) that were prepared by mating with vasectomized males. Mice carrying this knock in allele (hereafter referred to as Marf1 D272A ) were identified by PCR followed by sequencing using primers shown in Supplementary Table 2 .
Fertility and allelic complementation test
Fertility test was carried out by mating the 6-week old female mice (three of each genotype) with normal adult C57BL/6J X DBA2 (B6D2) F1 males with proven fertility for 8-10 months. The number of pups for each litter was recorded at birth, and the average number of pups per litter was calculated at the end of the testing period.
For allelic complementation test, mice carrying both the gene trap allele and D272A mutant allele (hereafter referred to as Marf1 D272A/GT ) were obtained by breeding the Marf1 D272A/+ female mice with Marf1 GT/GT males. The resultant Marf1 D272A/GT females were then subjected to either fertility test or superovulation and histology analyses.
Histology
These were carried out exactly as described previously (2) . Briefly, the ovaries and the oviductal ampulla containing the ovulated cumulus oocyte-complexes (COCs) inside were first fixed for 2-3 h at room temperature in Bouin's fixative, and then dehydrated in ethanol and xylene, and embedded in paraffin. The blocks were serially sectioned at 5-μm thickness, and stained with periodic acidSchiff reagent and Lillie-Mayer hematoxylin.
Cloning, expression and purification of recombinant MARF1
The gene encoding MmMARF1(residues 158-1381, referred as MARF1) was cloned into pfastBacHTB vector (Thermo Fisher Scientific Inc., Waltham, MA, USA). Bacmids and baculoviruses were generated following the instructions for the Bac-to-Bac baculovirus expression system (Thermo Fisher Scientific Inc.). Sf9 insect cells were cultured in SIM SF medium (Sino Biological Inc.) at 27°C for 48 h after infection with 1% P2 baculoviruses. The insect cells were harvested, and then resuspended in buffer 1(20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 10 mM imidazole, 5% glycerol and 1mM PMSF), lysed by sonication, and centrifuged. The supernatant was picked out and incubated with 2 ml Ni-NTA Beads (Qiagen, Germantown, MD, USA) for 1 hours at 4°C. After wash by 10 ml Buffer 1, proteins were eluted by the buffer 2 (20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 500 mM imidazole, 5% glycerol). The protein was further purified by Hiload Superdex 200 16/600 (GE Healthcare) and concentrated to about 10 mg/ml in a storage buffer of 20 mM Tris, pH 7.5, 300 mM NaCl and 2 mM DTT.
column and Hiload Superdex 200 16/600 column (GE Healthcare), and stored in the buffer of 20 mM Tris, pH 7.5, 500 mM NaCl and 2 mM DTT.
Amino acid substitution
L253M, L303M, D178A, D215A, D246A and D272) were introduced into the plasmids by sitedirected mutagenesis using the QuikChange II XL kit (Catalog # 200517, Agilent Technologies, Beijing, China) according to the manufacturer's instructions. Mutant proteins were expressed and purified in the same manner as the wild-type protein.
Crystallization
Crystals were grown by hanging drop vapour diffusion at 18°C. SeMet-LOTUS1 proteins were concentrated to 20 mg/ml. Crystals of SeMet-LOTUS1 were obtained by mixing 1 μl protein and 1 μl reservoir solution (1.5 M (NH 4 ) 2 SO 4 , 0.1 M Citrate pH5.5). SeMet-NYN L253M/L303M proteins were concentrated to 16 mg/ml. Crystals of SeMet-NYN were obtained by mixing 1 μl protien and 1 μl reservoir solution (22% PEG-3350, 100 mMTris-HCl pH 8.5, and 200 mM Li 2 SO4). The crystals were soaked into the reservoir solution supplemented with 25% glycerol before flash-cooling into liquid nitrogen for diffraction data collection.
Data collection, structure determination and refinement
SeMet-LOTUS1 crystal diffraction data was collected at BL-19U1 (SSRF, China) and data sets were processed and scaled using the HKL3000 package (3). SeMet-NYN crystal diffraction data was collected at BL-17U1 (SSRF, China) and data sets were processed and scaled using the iMOSFLM package (4). The SeMet-LOTUS1and SeMet-NYN structure were solved using SAD method with the Autosol program embedded in the Phenix suit (5-7).The initial models were adjusted with the program COOT (8) . All refinements were carried out using the REFMAC program (9) . The crystallographic data and refinement statistics for the structure were shown in Supplementary Table 1 . Figures were prepared using PyMol (Pymol Molecular Graphics System, LLC). Atomic coordinates and structure factors for the reported crystal structures have been deposited at the Protein Data Bank under accession codes 5YAA (NYN domain) and 5YAD (LOTUS1 domain).
Nucleic acid Preparation
The ssRNA H49 and H49AS were obtained by in vitro transcription. The templates of H49 and H49AS were obtained by PCR using primers shown in Supplementary Table 2 , and were transcribed with T7 RNA polymerase. The RNA transcripts were urea gel purified. The 5' terminus of unlabelled H49 was dephosphorylated by CIP (New England Biolabs, Ipswich, MA, USA) for 1 h at 37°C, and then purified by using standard procedures. Forty-nine nt ssRNA treated with CIP were 5′-radiolabeled with 32 P-γ-ATP (Perkin Elmer Health Sciences, Shanghai, China) and T4 polynucleotide kinase (New England Biolabs). Free ATP was removed and the buffer was exchanged using MicroSpin G-25 Columns (Roche, Shanghai, China). To prepare the dsRNA substrates, the radiolabeled strands were mixed with 2-fold excess of the non-labeled, complementary strands in buffer (10 mM Tris-HCl, pH 7.5, 50 mM NaCl), heated at 95°C for 5 min, and then gradually cooled to 25°C. To prepare the circular ssRNA substrate, the 5' terminal radiolabeled H49 was incubated at 37°C for 15 min with ATP and T4 RNA ligase 1 (New England Biolabs) and then purified by 20% denaturing PAGE.
Nuclease activity assay
Recombinant proteins and 5' 32 P-labelled substrates were incubated at 37 °C for 5 min in the reaction buffer containing 20 mM Tris-HCl, pH 7.5,150 mM NaCl, 1 mM DTT and 1 mM MgCl 2 . The concentration of the substrates was 20 nM, the final concentration of the recombinant MARF1 proteins were indicated in the figures of the corresponding experiments. The reactions were terminated by addition of 2×loading buffer (90% formamide, 20 mM EDTA, 0.1% SDS and 0.02% bromophenol blue). Samples were heated at 95 °C for 5 minutes, centrifuged and loaded onto 16% urea PAGE followed by electrophoresis. Products were detected by autoradiography using Typhoon FLA-9000 imaging system (GE Healthcare).
Electrophoretic mobility shift assay
Recombinant proteins and 5' 32 P-labelled substrates were incubated at 25 °C for 30 min in the reaction buffer containing 20 mM Tris-HCl, pH 7.5 and 150 mM NaCl. The final concentration of the recombinant MARF1 proteins were indicated in the figures of the corresponding experiments. After adding 6×loading buffer (12% ficoll 400, 0.012% bromophenol blue and 0.012% xylene cyanol), samples were loaded onto 8% native PAGE, then separated by electrophoresis. Products were detected by autoradiography using Typhoon FLA-9000 imaging system (GE Healthcare).
Oocyte isolation, in vitro fertilization and embryo culture
Fully-grown oocytes (FGOs) were isolated from the large antral follicles of equine chorionic gonadotropin (eCG, Ningbo A Second Hormone Factory, Cixi, China) primed (46 h) 22-d old mice as described previously (10) . Ovulated COCs were obtained from the ampulla of oviducts following a super-ovulation regimen for mice (2) . For IVF, the ovulated oocytes with visible first polar bodies were inseminated with normal sperm isolated from B6D2F1 adult males. 2-cell stage embryos were collected 24 h after IVF. Media used for oocyte collection and culture were bicarbonate-buffered MEM-alpha (Thermo Fisher Scientific Inc.) with Earles' salts, supplemented with 75 μg/ml penicillin G, 50 μg/ml streptomycin sulfate, 0.23 mM pyruvate, and 3 mg/ml bovine serum albumin. Oocytes and embryos cultures were carried out at 37 ºC in an Eppendorf New Brunswick Galaxy170R incubator (Hamburg, Germany) infused with 5% O 2 , 5% CO 2 and 90% N 2 .
Cloning and site-directed mutagenesis of Marf1
The Marf1 coding sequence was cloned into the pCMV6-AC-3DDK plasmid (Catalog# PS1000057, OriGene Technologies, Rockville, MD, USA) using the In-Fusion HD Cloning Kit (Catalog# 121416, Takara Biomedical Technology Co., Ltd., Beijing, China) according to the manufacturer's instructions and primers shown in Supplementary Table 2. D272A-mutation of Marf1 was then achieved through site-directed mutagenesis using QuikChange XL Site-Directed Mutagenesis Kit (Catalog # 200517, Agilent Technologies) according to the manufacturer's instructions and primers shown in Supplementary Table 2. These plasmid DNAs were then linearized and transcribed in vitro using the Ambion's mMESSAGE mMACHINE kit (Applied Biosystems/Ambion, Austin, TX), and the resultant mRNA were then polyadenylated in vitro using the Poly (A) Tailing Kit (Applied Biosystems/Ambion) and purified using the RNeasy micro kit (Qiagen, Valencia, CA) as described previously (2) .
Microinjection of oocytes with mRNA
The purified mRNAs of WT-and D272A-mutant Marf1 were adjusted into a final concentration of ~500 ng/µl, and were then microinjected into the cytoplasm of Marf1
GT/GT GV-stage FGOs in M2 medium containing 10% fetal bovine serum. Approximately 10 pl of the mRNA was injected into one oocyte. After injection, the oocytes were cultured for 40 h in 5 μM milrinone-containing medium to maintain GV-arrest, and then collected for RNA-Seq or real-time RT-PCR analyses.
RNA-Seq analysis
Four sets of samples with each containing 80 WT-, Marf1 GT/GT and Marf1 D272A/D272A GV-stage FGOs, or 80 Marf1 GT/GT GV-stage FGOs after receiving the microinjection with WT-and D272A-mutant Marf1 mRNAs were collected for RNA-Seq analysis. Total RNA was extracted using the RNeasy Micro Kit (Qiagen, Germantown, MD, USA) according to manufacturer's instructions, and then subjected to mRNA isolation using NEB Next Poly (A) mRNA Magnetic Isolation Module (NEB). Construction of the mRNA library, which includes sequential RNA fragmentation, reverse transcription using random primers, second strand cDNA synthesis, end repair, dA-tailing, adapter ligation, U excision, and PCR enrichment, was carried out using NEB Next Ultra TM RNA Library Prep Kit for Illumina (NEB, Ipswich, MA) according to the instruction manual. The libraries were sequenced on an Illumina HiSeq X Ten platform with 150bp pair-end reads. All reads passed filter were trimmed to remove adaptor sequences and low-quality bases, and the FPKMs were calculated and normalized using cufflinks (v2.2.1). Reads were aligned to the mm10 genome reference using tophat2 (v2.0.13), and the differentially expressed genes were calculated using default parameter of cuffdiff (v2.2.1). RNA-Seq data are deposited in the Gene Expression Omnibus (datasets GSE109213).
Gene enrichment analysis of differentially expressed transcripts was carried out using Metascape (http://metascape.org), a gene annotation and analysis resource, as described previously (11) .
qRT-PCR analysis
Three sets of samples with each sample containing 100 WT-, Marf1
GT/GT and Marf1 D272A/D272A GVstage FGOs, or 100 Marf1 GT/GT GV-stage FGOs after receiving the microinjection with WT-and D272A-mutant Marf1 mRNAs were collected for this analysis. Total RNA isolation and reverse transcription, as well as real-time PCR quantification of the steady-state levels of mRNA in oocytes, were carried out as described previously (12) . Primer pairs used for this analysis were shown in Table S2 .
Western blot analysis
Eighty WT-and mutant Marf1 GV-stage FGOs were collected and subjected to Western blot analysis for MARF1 and ACTB using the same antibodies as described previously (12) (2, 13) .
Detection and confocal microscopic imaging of DNA double-stranded breaks in oocytes
These were carried out as described previously using the anti-γH2AX primary antibody (catalog no. BS4760; 1:100 dilution; Bioworld technology, St. Louis Park, MN) and the Alexa fluor 594-conjugated secondary antibodies (Thermo Fisher Scientific) (2). The DNA was counterstained with DAPI. The staining was examined and imaged under a LSM 710 confocal laser scanning microscope (Zeiss). Images for WT and Marf1 D272A/D272A oocytes were taken under exactly the same sets of parameters, and number of positively stained foci were counted and calculated. , Marf1 GT/GT and Marf1 D272A/GT ) mice without hormonal treatment (referred to as 21-day), or being treated with eCG for 46 h (referred to as eCG 46 h), or being treated with eCG for 46 h followed by hCG for another 10 h (referred to as hCG 10 h). The magnified view of the ovulating follicles in the hCG 10 h-group were shown on the right side of the whole ovaries. Arrowheads indicate the MII spindle and first polar body, arrows indicate GV. Scale bars indicate 100 μm. 
